http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101802251-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101802251-B1 |
| titleOfInvention | Vaccine composition for preventing or treating alzheimer disease or dementia comprising amyloid beta peptide and bee venom phospholipase A2 as active ingredient |
| abstract | The present invention relates to a cytotoxic agent composition for preventing or treating Alzheimer's disease or dementia comprising amyloid beta (Aβ) peptide and bvPLA2 (bee venom phospholipase A2) as an active ingredient. Specifically, the present invention relates to a cell therapeutic composition for preventing or treating amyloid beta ) Peptide and vPLA2 (bee venom phospholipase A2) of SEQ ID NO: 2 are used as a vaccine to provide a vaccine composition for preventing or treating Alzheimer's disease or dementia. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021006420-A1 |
| priorityDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 370.